{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:36Z","timestamp":1790739276378,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.nefro.2017.03.028","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T14:45:23Z","timestamp":1497624323000},"page":"622-629","source":"Crossref","is-referenced-by-count":3,"title":["Perfil antiinflamatorio del paricalcitol en el receptor de trasplante renal"],"prefix":"10.1016","volume":"37","author":[{"given":"Javier","family":"Donate-Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Henr\u00edquez-Palop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mart\u00edn-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Hern\u00e1ndez-Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayra","family":"P\u00e9rez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Muros-de-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mora-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2017.03.028_bib0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.TP.0000043926.74349.6D","article-title":"Bone disease after renal transplantation","volume":"75","author":"Heaf","year":"2003","journal-title":"Transplantation."},{"key":"10.1016\/j.nefro.2017.03.028_bib0215","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: Results of an open label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefro.2017.03.028_bib0220","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.03.028_bib0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.028_bib0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","article-title":"Inflammation in end-stage renal disease: The hidden enemy","volume":"11","author":"Stenvinkel","year":"2006","journal-title":"Nephrology (Carlton)."},{"key":"10.1016\/j.nefro.2017.03.028_bib0235","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1681\/ASN.2006080926","article-title":"Inflammatory syndrome in patients on hemodialysis","volume":"17","author":"Jofr\u00e9","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0240","first-page":"S22","article-title":"Alterations of the cytokine network in hemodialysis","volume":"14","author":"Tetta","year":"2001","journal-title":"J Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-a central factors in the altered cytokine network of uremia\u2014The good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.028_bib0250","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11255-011-0098-4","article-title":"CRP and acute renal rejection: A marker to the point","volume":"44","author":"Roshdy","year":"2012","journal-title":"Int Urol Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0255","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","article-title":"Inflammation-associated graft loss in renal transplant recipients","volume":"26","author":"Dahle","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.028_bib0260","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/jch.12634","article-title":"Inflammation and atherosclerosis are associated with hypertension in kidney transplant recipients","volume":"17","author":"Azancot","year":"2015","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.nefro.2017.03.028_bib0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.05.016","article-title":"Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients","volume":"212","author":"Roe","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.nefro.2017.03.028_bib0270","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2215\/CJN.00930209","article-title":"Inflammation in renal transplantation","volume":"4","author":"Abedini","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0275","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00684.2011","article-title":"In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt\/beta-catenin activation","volume":"303","author":"Mart\u00ednez-Moreno","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0280","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D Receptor-mediated sequestration of NF-kB signaling","volume":"19","author":"Tan","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ki.2009.346","article-title":"Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy","volume":"76","author":"Tan","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.028_bib0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","article-title":"Blockade of Wnt\/\u03b2-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury","volume":"22","author":"He","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0295","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/ndt\/gfr555","article-title":"The effect of vitamin D derivates on vascular calcification associated to inflammation","volume":"27","author":"Guerrero","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.028_bib0300","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant recipients","volume":"95","author":"Gonz\u00e1lez","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.nefro.2017.03.028_bib0305","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.nefro.2015.06.018","article-title":"Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism","volume":"35","author":"Borrego Utiel","year":"2015","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.nefro.2017.03.028_bib0310","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gft227","article-title":"Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: Results of the VITAL study","volume":"28","author":"Coyne","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.028_bib0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ndt\/gfh1015","article-title":"Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation","volume":"19","author":"Fern\u00e1ndez-Fresnedo","year":"2004","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.nefro.2017.03.028_bib0320","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","article-title":"Proteinuria after kidney transplantation, relationship to allograft histology and survival","volume":"7","author":"Amer","year":"2007","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefro.2017.03.028_bib0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/TP.0b013e31828719fb","article-title":"Low-grade proteinuria and oligoalbuminuria in renal transplantation","volume":"96","author":"Halimi","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.nefro.2017.03.028_bib0330","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.028_bib0335","first-page":"716","article-title":"Vitamin D and proteinuria: A critical review of molecular bases and clinical experience","volume":"33","author":"P\u00e9rez-G\u00f3mez","year":"2013","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2017.03.028_bib0340","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200767140-00003","article-title":"Nonclassical aspects of differential vitamin D receptor activation: Implications for survival in patients with chronic kidney disease","volume":"67","author":"Andress","year":"2007","journal-title":"Drugs."},{"key":"10.1016\/j.nefro.2017.03.028_bib0345","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bies.10368","article-title":"The pleiotropic actions of vitamin D","volume":"26","author":"Lin","year":"2004","journal-title":"Bioessays."},{"key":"10.1016\/j.nefro.2017.03.028_bib0350","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1152\/ajprenal.00090.2011","article-title":"Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy","volume":"302","author":"Sanchez-Ni\u00f1o","year":"2011","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0355","doi-asserted-by":"crossref","first-page":"e63186","DOI":"10.1371\/journal.pone.0063186","article-title":"Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells","volume":"17","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nefro.2017.03.028_bib0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.nefro.2017.03.028_bib0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2369-13-159","article-title":"Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients","volume":"13","author":"Izquierdo","year":"2012","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0370","doi-asserted-by":"crossref","first-page":"670475","DOI":"10.1155\/2014\/670475","article-title":"Selective vitamin D receptor activation as an anti-inflammatory target in chronic kidney disease","volume":"2014","author":"Donate-Correa","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.nefro.2017.03.028_bib0375","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jcph.19","article-title":"Anti-inflammatory profile of paricalcitol in hemodialysis patients: A prospective, open-label, pilot study","volume":"53","author":"Navarro-Gonz\u00e1lez","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11255-009-9541-1","article-title":"Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells","volume":"42","author":"Eleftheriadis","year":"2010","journal-title":"Int Urol Nephrol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0385","doi-asserted-by":"crossref","first-page":"765364","DOI":"10.1155\/2015\/765364","article-title":"Role of paricalcitol in modulating the immune response in patients with renal disease","volume":"2015","author":"Lucisano","year":"2015","journal-title":"Int J Endocrinol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0390","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points to control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.nefro.2017.03.028_bib0395","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"10.1016\/j.nefro.2017.03.028_bib0400","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1161\/01.STR.30.10.2174","article-title":"Increased I.L-1beta IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study","volume":"30","author":"Kostulas","year":"1999","journal-title":"Stroke."},{"key":"10.1016\/j.nefro.2017.03.028_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/CS20020367","article-title":"Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction","volume":"105","author":"Akatsu","year":"2003","journal-title":"Clin Sci."},{"key":"10.1016\/j.nefro.2017.03.028_bib0410","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:08:56Z","timestamp":1530032936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699517301029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0211699517301029"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2017.03.028","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}